|Day Low/High||3.56 / 3.70|
|52 Wk Low/High||2.80 / 9.95|
Investors in BioCryst Pharmaceuticals, Inc. saw new options become available this week, for the March 2016 expiration.
The most recent short interest data has been released by the NASDAQ for the 06/30/2015 settlement date, which shows a 2,400,172 share decrease in total short interest for BioCryst Pharmaceuticals, Inc. , to 9,652,920, a decrease of 19.91% since 06/15/2015.
Here are Tuesday's top research calls, including new coverage of Fitbit and an upgrade of Lowe's.
Stocks with insider trader activity include UG, BCRX and EA
Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate
Stocks with insider trader activity include GPK, HPQ and BCRX
Stocks with insider trader activity include BDN, MRCY and BCRX
In trading on Monday, shares of BioCryst Pharmaceuticals, Inc. crossed above their 200 day moving average of $10.97, changing hands as high as $11.17 per share.
Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "perilous reversal" (up big yesterday but down big today) candidate
The shares of drug maker Dyax are surging after the company last night reported data from a Phase 1b clinical trial of its DX-2930 drug, a treatment for hereditary angioedema...
BioCryst (BCRX) share are climbing after the company announced a contract with the U.S. Department of Health and Human Services to develop an Ebola treatment.
BARDA Awards NDA Enabling CMC & Non-Clinical Toxicology Studies Contract for BCX4430
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Stocks with insider trader activity include MKSI, BCRX and CSGS
Cramer isn't excited by Yahoo!, would buy more Xcel Energy and likes Cisco over Arris Group.
Despite the many strides the market has made since 2000, critics are once again calling the Nasdaq overvalued and in 'bubble' territory. Cramer details why they're wrong.
The most recent short interest data has been released by the NASDAQ for the 01/30/2015 settlement date, which shows a 1,102,518 share increase in total short interest for BioCryst Pharmaceuticals, Inc. , to 12,060,331, an increase of 10.06% since 01/15/2015.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.